|Grant ID: R1218|
Recruitment of First-Time, Tenure-Track Faculty Members
University of California, San Diego
August 02, 2012
Triple-negative breast cancer, which lacks receptors for the three most common hormones known to fuel breast cancer, can be aggressive and difficult to treat. It doesn’t respond to traditional hormone-blocking therapies and is more likely to recur and metastasize after chemotherapy.
Now a researcher at MD Anderson Cancer Center is trying to find better treatments for this often-deadly disease, by thinking about triple-negative breast cancer in a new way. Liuqing Yang was recruited in 2013 to the department of molecular and cellular oncology, with the help of a First-Time Tenure-Track Award from CPRIT. He was a postdoctoral fellow at the University of California, San Diego.